In a pandemic milestone, the NIH ends guidance on COVID treatment
The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.
COVID treatments
COVID test kits, treatments and vaccines won't be free to many consumers much longer
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?
The drug is the most effective way to cut the risk of severe disease. It's heading to China now. Yet the drug is underused in some places. Why? And are there options if you're not a good candidate?
How monoclonal antibodies lost the fight with new COVID variants
The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.
3 ways to get COVID pills, if you've just tested positive
Some people have had trouble getting Paxlovid pills quickly, despite the administration's effort to ease access after a COVID test confirms infection.
Lifesaving COVID drugs are sitting unused on pharmacy shelves, HHS data shows
States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker.
Feds' contract with Pfizer for Paxlovid has some surprises
NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.
Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised
So far the government has distributed about 300,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.
The COVID antiviral drugs are here but they're scarce. Here's what to know
Paxlovid and molnupiravir have been authorized for emergency use to keep COVID-19 patients out of the hospital, but don't expect to be able to go to your usual pharmacy and get them.
FDA authorizes 1st antiviral pill for COVID
In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.